[Invasive pulmonary aspergillosis in AIDS]

Area of Science:

• Medical Mycology
• Infectious Diseases
• Pulmonology

Background:

• Invasive pulmonary aspergillosis (IPA) is a severe fungal infection.
• Risk factors for IPA in HIV-negative individuals include neutropenia and immunosuppressive therapies.
• Risk factors for IPA in HIV-positive patients, particularly those with advanced HIV/AIDS, remain poorly defined.

Purpose of the Study:

• To identify risk factors for invasive pulmonary aspergillosis in HIV-positive patients.
• To compare risk factors between HIV-positive patients with IPA and matched controls.

Main Methods:

• A case-control study was conducted at Bichat-Claude Bernard Teaching Hospital, Paris, France (1991-1996).
• Eight cases of IPA in HIV-positive patients were matched with 24 controls (CD4 count < 50/mm3).
• Data collected included demographics, CD4 counts, AIDS duration, neutropenia, corticosteroid/chemotherapy history, opportunistic infections, lung cavities, and hospitalization duration.

Main Results:

• No significant differences were observed in age, CD4 counts, AIDS duration, neutropenia, corticosteroid therapy, chemotherapy, or prior opportunistic infections between cases and controls.
• Cases were significantly more likely to have a pre-existing lung cavity (3/8 vs. 0/24, P = 0.01).
• Cases also had significantly longer hospital stays in the previous year (7 weeks vs. 2.8 weeks, P = 0.02).

Conclusions:

• Neutropenia and immunosuppressive treatments do not appear to be significant risk factors for IPA in patients with advanced HIV/AIDS.
• Pre-existing lung cavities and frequent hospitalizations are identified as potential risk factors for invasive pulmonary aspergillosis in this population.
• These findings highlight the need for targeted surveillance and preventive strategies in high-risk HIV-positive patients.